Pulsed Electromagnetic Field Therapy RCT Aims to Improve Muscle Strength and Function in End-Stage Knee Osteoarthritis Patients
Background
End-stage knee osteoarthritis (OA) is a prevalent musculoskeletal condition, with over 34,000 patients in Hong Kong awaiting joint replacement. The average waiting time for total knee replacement (TKR) is exceptionally long, at 122 months, leading to severe pain and limited daily activities for many elderly individuals. Maintaining preoperative knee-extensor strength is crucial, as improved strength can potentially postpone the need for surgery and enhance post-TKR functional recovery. There is a significant need for interventions that can improve the well-being of this large and growing patient population while surgical capacity remains limited.
Study Design
This study describes the design of a randomized controlled trial (RCT) investigating the effects of Pulsed Electromagnetic Field (PEMF) therapy. The trial aims to enroll 80 patients with end-stage knee osteoarthritis who are awaiting total knee replacement (TKR). Participants will be randomized to receive either PEMF therapy in addition to standard rehabilitation, or standard rehabilitation alone. The primary endpoints include assessing muscle strength and functional performance both before and after TKR. The study design is a double-blinded, placebo-controlled RCT, aiming to compare the efficacy of PEMF as an adjunct to standard care.
Results
This randomized controlled trial is designed to examine if Pulsed Electromagnetic Field (PEMF) therapy, when added to standard rehabilitation, can improve muscle strength and functional performance in patients with end-stage knee osteoarthritis before and after total knee replacement (TKR). The study hypothesizes that PEMF exposure, alongside regular exercise, may promote the secretion of myokine and facilitate muscle regeneration, thereby enhancing knee-extensor strength.
As an ongoing trial (NCT05548712) with an estimated completion in September 2024, specific results and quantitative findings, including p-values, percentages, or fold-changes, are not yet available from this abstract. The research aims to provide the first RCT evidence on PEMF's impact in this specific patient population.
Key Findings
- RCT aims to assess if PEMF improves muscle strength in end-stage knee OA patients.
- Investigates PEMF's effect on functional performance before and after TKR.
- Hypothesizes PEMF promotes
myokinesecretion and muscle regeneration. - First RCT to examine PEMF in end-stage knee OA patients awaiting TKR.
Why It Matters
If PEMF therapy proves effective, it could offer a significant non-pharmacological intervention for patients with end-stage knee osteoarthritis facing long waits for total knee replacement. This could improve quality of life, reduce pain, and enhance functional capacity during a challenging period. A successful outcome might lead to the integration of PEMF into standard preoperative rehabilitation protocols, potentially delaying surgery or improving post-surgical recovery. While specific dosing and frequency details are part of the trial protocol, the abstract highlights the potential for PEMF to complement existing exercise regimens by promoting myokine secretion and muscle regeneration, offering a novel approach to muscle maintenance in this vulnerable population.
knee osteoarthritis
pemf
rct
muscle strength
rehabilitation
joint replacement